Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Apr 13;14(8):1617.
doi: 10.3390/nu14081617.

Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women

Juan J López-Gómez  1   2 , José L Pérez-Castrillón  2   3 , Isabel García de Santos  4 , María Pérez-Alonso  2 , Olatz Izaola-Jauregui  1   2 , David Primo-Martín  1   2 , Daniel A De Luis-Román  1   2
Affiliations
Observational Study

Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women

Juan J López-Gómez et al. Nutrients. .

Abstract

Background and aims: The relationship between obesity and bone metabolism is controversial. In recent decades, the protective role of obesity in the development of osteoporosis is questioned. The aims of this study are the following: to evaluate the differences in bone turnover markers between postmenopausal women with and without obesity and to compare the risk of fracture at five years between these groups. Methods: An observational longitudinal prospective cohort study of postmenopausal women with obesity (O) (body mass index (BMI) > 30 kg/m2) and non-obesity (NoO) (BMI < 30 kg/m2) is designed. 250 postmenopausal women are included in the study (NoO: 124 (49.6%) and O: 126 (50.4%)). It measures epidemiological variables, dietary variables (calcium intake, vitamin D intake, smoking, alcohol consumption, and physical activity), biochemicals (β-crosslap, type I procollagen amino-terminal peptide (P1NP), 25OH-vitamin D, and parathyroid hormone (PTH)), anthropometric variables, and fracture data five years after the start of the study. The mean age is 56.17 (3.91) years. Women with obesity showed lower levels of vitamin D (O: 17.27 (7.85) ng/mL, NoO: 24.51 (9.60) ng/mL; p < 0.01), and higher levels of PTH (O: 53.24 (38.44−65.96) pg/mL, NoO: 35.24 (25.36−42.40) pg/mL; p < 0.01). Regarding the bone formation marker (P1NP), it was found to be high in women without obesity, O: 45.46 (34.39−55.16) ng/mL, NoO: 56.74 (45.34−70.74) ng/mL; p < 0.01; the bone resorption marker (β-crosslap) was found to be high in women with obesity, being significant in those older than 59 years (O: 0.39 (0.14) ng/mL, NoO 0.24 (0.09) ng/mL; p < 0.05). No differences are observed in the risk of fracture at 5 years based on BMI (OR = 0.90 (95%CI 0.30−2.72); p = 0.85). Conclusions: Postmenopausal women with obesity showed lower levels of bone formation markers; older women with obesity showed higher markers of bone resorption.

Keywords: bone metabolism; bone turnover markers; fracture; obesity; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Differences in type fracture depending on body mass index (BMI).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ström O., Borgström F., Kanis J.A., Compston J., Cooper C., McCloskey E.V., Jönsson B. Osteoporosis: Burden, health care provision and opportunities in the EU: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch. Osteoporos. 2011;6:59–155. doi: 10.1007/s11657-011-0060-1. - DOI - PubMed
    1. Hernlund E., Svedbom A., Ivergård M., Compston J., Cooper C., Stenmark J., McCloskey E.V., Jönsson B., Kanis J.A. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch. Osteoporos. 2013;8:136. doi: 10.1007/s11657-013-0136-1. - DOI - PMC - PubMed
    1. Fassio A., Idolazzi L., Rossini M., Gatti D., Adami G., Giollo A., Viapiana O. The obesity paradox and osteoporosis. Eat. Weight Disord. EWD. 2018;23:293–302. doi: 10.1007/s40519-018-0505-2. - DOI - PubMed
    1. Gonnelli S., Caffarelli C., Nuti R. Obesity and fracture risk. Clin. Cases Miner. Bone Metab. 2014;11:9–14. doi: 10.11138/ccmbm/2014.11.1.009. - DOI - PMC - PubMed
    1. López-Gómez J.J., Pérez Castrillón J.L., de Luis Román D.A. Impact of obesity on bone metabolism. Endocrinol. Nutr. 2016;63:551–559. doi: 10.1016/j.endonu.2016.08.005. - DOI - PubMed

Publication types